Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084640

« Back to Dashboard
NDA 084640 describes DIPHEN, which is a drug marketed by Morton Grove, Usl Pharma, Whiteworth Town Plsn, Elkins Sinn, Pioneer Pharms, Mutual Pharm, Impax Labs, Cumberland Swan, Pharm Assoc, Halsey, Hi Tech Pharma, Eurohlth Intl Sarl, Alra, Kv Pharm, Bel Mar, Heather, Pvt Form, Watson Labs, Vangard, Sandoz, Nexgen Pharma Inc, Roxane, Lederle, Purepac Pharm, Barr, Lannett, Superpharm, Hospira, Cenci, Newtron Pharms, Perrigo, Ivax Sub Teva Pharms, App Pharms, Lyphomed, Hikma Intl Pharms, Watson Labs Inc, Teva, Bundy, Anabolic, LNK, Wyeth Ayerst, Naska, Mk Labs, Sun Pharm Inds, Valeant Pharm Intl, Alpharma Us Pharms, Mylan Institutional, Fresenius Kabi Usa, Abraxis Pharm, Intl Medication, Inwood Labs, Ani Pharms Inc, Parke Davis, Ascot, R And S Pharma, Par Pharm, Mylan, Hikma Pharms Llc, Able, and Scherer Rp, and is included in ninety-eight NDAs. Additional details are available on the DIPHEN profile page.

The generic ingredient in DIPHEN is phenytoin sodium. There are nineteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the phenytoin sodium profile page.

Summary for NDA: 084640

Usl Pharma
diphenhydramine hydrochloride
Therapeutic Class:Antiemetics
Antiparkinson Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:ELIXIR;ORALStrength12.5MG/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.